Bristol-Myers Squibb Co
FDA approves Bristol Myers Squibb’s schizophrenia drug
Craig Fedirighi
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s ...
Bristol Myers Squibb (BMY) earnings Q2 2024
Craig Fedirighi
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman ...
Pfizer stock recovers after Covid decline but some employees struggle
Craig Fedirighi
Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, ...
Bristol Myers Squibb (BMY) earnings Q1 2024
Lawrence Booth
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. ...
